Announced Mon, 27 Jul · 13:08 IST
Thyrocare Q1 FY27: Revenue up 24 percent, PAT INR51 cr, specialty launch
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹565.50
prior close
₹589.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0-0.4-0.9+2.2—————————
Up moveDown movePending
AI summary
Thyrocare Q1 FY27 consolidated revenue INR240 crore up 24.3 percent YoY, standalone INR225.6 crore up 26.1 percent. Pathology business grew 26 percent. EBITDA margin 32.2 percent, PAT INR51.3 crore up 34 percent YoY. Active franchisees at 11,700. Launched specialty diagnostics in allergy and genomics. Board approved divestment of radiology business, expected 6 month timeline. Plans Thyrocare-branded consumables launch by September.
Likely market impact
Strong Q1 with 34 percent PAT growth and margin expansion. Specialty foray adds new growth avenues. Radiology divestment sharpens focus.